[go: up one dir, main page]

BR112018000734A2 - composições tópicas retinoicas - Google Patents

composições tópicas retinoicas

Info

Publication number
BR112018000734A2
BR112018000734A2 BR112018000734A BR112018000734A BR112018000734A2 BR 112018000734 A2 BR112018000734 A2 BR 112018000734A2 BR 112018000734 A BR112018000734 A BR 112018000734A BR 112018000734 A BR112018000734 A BR 112018000734A BR 112018000734 A2 BR112018000734 A2 BR 112018000734A2
Authority
BR
Brazil
Prior art keywords
topical compositions
retinoic
present application
application relates
compositions
Prior art date
Application number
BR112018000734A
Other languages
English (en)
Inventor
Manish M Bankar
Sujit Kumar Dolai
Sateesh Kandavilli
Franklin Okumu
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of BR112018000734A2 publication Critical patent/BR112018000734A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A61C19/08—Implements for therapeutic treatment combined with anaesthetising implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

o presente pedido refere-se a composições tópicas. em particular, o presente pedido refere-se a uma composição tópica, compreendendo um retinoide como agente ativo e excipiente(s) farmaceuticamente aceitável(is) e a um processo para preparação de tais composições. além disso, o presente pedido refere-se ao método para uso das composições tópicas no tratamento de doenças de pele, tais como acne, rosácea, psoríase, etc.
BR112018000734A 2015-07-13 2016-07-13 composições tópicas retinoicas BR112018000734A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562191937P 2015-07-13 2015-07-13
PCT/US2016/042168 WO2017011600A1 (en) 2015-07-13 2016-07-13 Topical retinoid compositions

Publications (1)

Publication Number Publication Date
BR112018000734A2 true BR112018000734A2 (pt) 2018-09-04

Family

ID=56550383

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018000734A BR112018000734A2 (pt) 2015-07-13 2016-07-13 composições tópicas retinoicas

Country Status (15)

Country Link
US (5) US9707216B2 (pt)
EP (1) EP3322401A1 (pt)
JP (1) JP6666992B2 (pt)
KR (1) KR20180026740A (pt)
CN (1) CN108024954A (pt)
AU (1) AU2016294504B2 (pt)
BR (1) BR112018000734A2 (pt)
CA (1) CA2992107A1 (pt)
CO (1) CO2018001375A2 (pt)
EA (1) EA034808B1 (pt)
MX (1) MX2018000421A (pt)
NZ (1) NZ738815A (pt)
RU (1) RU2699027C2 (pt)
WO (1) WO2017011600A1 (pt)
ZA (1) ZA201800080B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
CN108024954A (zh) * 2015-07-13 2018-05-11 瑞迪博士实验室有限公司 局部用类视黄醇组合物
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US9987239B1 (en) * 2017-03-14 2018-06-05 Rey Ventures, LLC Pharmaceutical retinoid preparation for topical use
US11318077B2 (en) 2017-09-29 2022-05-03 Rodan & Fields, Llc Retinaldehyde containing compositions and methods of use
US10653656B2 (en) * 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions
WO2020081983A1 (en) * 2018-10-19 2020-04-23 Topix Pharmaceuticals, Inc. Retinol formulations and skin treatment methods thereof
CN112386565B (zh) * 2019-08-02 2024-09-13 北京盈科瑞创新医药股份有限公司 一种马钱子碱凝胶制剂及其制备方法
AU2020407398C1 (en) * 2019-12-20 2025-07-24 Advansix Resins & Chemicals Llc Surfactants for use in healthcare products
JP7451717B2 (ja) 2019-12-31 2024-03-18 アドバンシックス・レジンズ・アンド・ケミカルズ・リミテッド・ライアビリティ・カンパニー 油及びガス生産のための界面活性剤
US20220233489A1 (en) * 2021-01-28 2022-07-28 Chemistryrx Kits for dermal care
DE102022212093A1 (de) * 2022-11-15 2024-05-16 Beiersdorf Aktiengesellschaft Waschformulierung gegen Akne
FR3147098A1 (fr) * 2023-03-28 2024-10-04 L'oreal Composition à deux phases

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965275A (en) * 1974-02-11 1976-06-22 Commercial Solvents Corporation Composition and method
FR2350095A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4154823A (en) * 1976-06-10 1979-05-15 Schutt Steven R Skin treatment compositions and methods of using same
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5445823A (en) * 1994-10-20 1995-08-29 The Procter & Gamble Company Dermatological compositions and method of treatment of skin lesions therewith
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US6338855B1 (en) 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
US5855893A (en) 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
CA2282682C (en) 1997-02-20 2008-08-19 Allergan Sales, Inc. Tazarotene and corticosteroid treatment for psoriasis
EP1011630B2 (en) * 1997-09-12 2008-10-15 The Procter & Gamble Company Cleansing and conditioning article for skin or hair
US6036963A (en) * 1998-02-26 2000-03-14 Chesebrough-Ponds's Usa Co., Division Of Conopco, Inc. Gluconolactones and glucarolactones as anti-irritants in cosmetic compositions
US6017938A (en) 1998-07-28 2000-01-25 Bershad; Susan Short contact treatment for acne
DE69934410T2 (de) * 1998-07-28 2007-09-27 Bershad, Susan Behandlung von akne und lichtbedingter alterung durch kurzzeitbehandlung mit topischen retinoiden
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
JP2000212082A (ja) * 1999-01-26 2000-08-02 Showa Denko Kk 皮膚用剤
US6114348A (en) * 1999-03-10 2000-09-05 Weber; Paul J. Method of treating warts using tazarotene
US6277881B1 (en) * 1999-05-27 2001-08-21 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids
US6385623B1 (en) * 1999-11-12 2002-05-07 Dell Usa, L.P. System and method for ensuring proper execution of scheduled file updates
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6495602B1 (en) * 2001-12-13 2002-12-17 Bradley Pharmaceuticals, Inc. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US6974570B1 (en) * 2002-10-30 2005-12-13 Griffith Dana K Shaving lotion kit and method of preparing skin and unwanted hair for shaving
ES2450133T3 (es) * 2003-01-24 2014-03-24 Stiefel Research Australia Pty Ltd Espuma de fosfato de clindamicina
EP1696868A1 (en) * 2003-07-18 2006-09-06 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
JP2007508243A (ja) * 2003-08-04 2007-04-05 フォーミックス エルティーディー． 両親媒性コポリマーゲル化剤を含む泡坦体
FR2871377B1 (fr) * 2004-06-11 2007-08-24 Galderma Res & Dev Gel depigmentant hydroalcoolique comprenant du mequinol et de l'adapalene
WO2006065991A2 (en) 2004-12-17 2006-06-22 Dr. Reddy's Laboratories Ltd. Dispersion for delivering active agents
FR2894821B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
FR2920967B1 (fr) * 2007-09-14 2009-10-23 Sederma Soc Par Actions Simpli Utilisation de l'hydroxymethionine en tant qu'actif anti age
DK2400951T3 (en) * 2009-02-25 2018-12-03 Mayne Pharma Llc TOPICAL FOAM COMPOSITION
SI3310389T1 (sl) * 2015-06-18 2020-11-30 Bausch Health Ireland Limited Topični sestavki, ki obsegajo kortikosteroid in retinoid za zdravljenje psoriaze
CN108024954A (zh) * 2015-07-13 2018-05-11 瑞迪博士实验室有限公司 局部用类视黄醇组合物

Also Published As

Publication number Publication date
US20180177774A1 (en) 2018-06-28
NZ738815A (en) 2019-10-25
US10716781B2 (en) 2020-07-21
US20210161875A1 (en) 2021-06-03
CA2992107A1 (en) 2017-01-19
US9931328B2 (en) 2018-04-03
EA034808B1 (ru) 2020-03-24
JP2018524366A (ja) 2018-08-30
CO2018001375A2 (es) 2018-06-20
KR20180026740A (ko) 2018-03-13
CN108024954A (zh) 2018-05-11
MX2018000421A (es) 2018-05-17
US20170281610A1 (en) 2017-10-05
ZA201800080B (en) 2020-02-26
US20170014398A1 (en) 2017-01-19
US20190224181A1 (en) 2019-07-25
RU2699027C2 (ru) 2019-09-03
WO2017011600A1 (en) 2017-01-19
AU2016294504B2 (en) 2019-07-18
US11026934B2 (en) 2021-06-08
RU2018105091A (ru) 2019-08-13
EA201890218A1 (ru) 2018-09-28
US9707216B2 (en) 2017-07-18
AU2016294504A1 (en) 2018-01-25
RU2018105091A3 (pt) 2019-08-13
EP3322401A1 (en) 2018-05-23
JP6666992B2 (ja) 2020-03-18

Similar Documents

Publication Publication Date Title
BR112018000734A2 (pt) composições tópicas retinoicas
BR112016000350A8 (pt) métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
BR112016021023A8 (pt) composições de corticosteroides tópicos
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
BR112019007815A2 (pt) composição de curativo tópico e método de preparação do mesmo para o tratamento de tecido de pele danificado
BR112017015004A2 (pt) reparação e rejuvenescimento de tecidos usando plasma rico em plaquetas.
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
PH12015501739B1 (en) Topical antifungal composition for treating onychomycosis
BR112013011064A2 (pt) uso cosmético nutracêutico ou oral e processo de tratamento cosmético oral
HK1220138A1 (zh) 用於皮肤抗老化处理的组合物
BR112015022025A8 (pt) composição e uso de um agente ativo
AR094035A1 (es) Estimulantes del colageno y su uso en el tratamiento de la piel
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos
BR112016006826A2 (pt) composição de spray tópico de halobetasol sem propelente, sistema de distribuição para a administração da composição de spray tópico, processo para a preparação da composição de spray tópico e método para o tratamento de condições de pele tópica
IN2013DE02943A (pt)
CR20160116A (es) Método para tratar onicomicosis con hidroxipropil quitasano
CY1119117T1 (el) Δερμοπροστατευτικη και δερμο-εξισορροπητικη συνθεση
BR112014032850A2 (pt) combinações de princípios ativos, preparações cosméticas ou dermatológicas, e, uso de combinações de princípios ativos
RS20130044A1 (en) PHARMACEUTICAL COMPOSITION FOR PSORIASIS REPAIR
BR112019007555A2 (pt) uso de miricetina e/ou um derivado de miricetina, composição e método de fabricação da composição
MX395001B (es) Composición y método para el tratamiento tópico del acné severo.
CO2017003203A1 (es) Composiciones farmacéuticas y/o cosméticas a base de cúrcuma
UA76330U (uk) Спосіб лікування запальних процесів

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2679 DE 10-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.